Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Max Birnstiel

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Concepts & Ideas

Molecular Sequence Data

Physiology

Disorders

Experimental Melanoma

Anatomy

Cultured Tumor Cells

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
16
Cotten, Matt
12
Buschle, Michael
12
Schmidt, Walter
8
Schaffner, G
8
Mechtler, Karl
7
Zatloukal, Kurt
5
Zauner, Wolfgang
4
Stingl, Georg
3
Schneeberger, Achim
3
Steinlein, Peter
3
Zenke, Martin
3
Wolff, Klaus
3
Mertelsmann, Roland
3
Kirlappos, Helen
2
Busslinger, Meinrad

Sign-in to see all Coauthors

Publications

TOP 3
Fritz Jörg H; Brunner Sylvia; Birnstiel Max L; Buschle Michael; Gabain Alexander v; Mattner Frank; Zauner Wolfgang
The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens.
Birnstiel Max L
The dawn of gene isolation.
Spinelli Giovanni; Birnstiel Max L
The modulator is a constitutive enhancer of a developmentally regulated sea urchin histone H2A gene.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Max Birnstiel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2004: Fritz Jörg H; Brunner Sylvia; Birnstiel Max L; Buschle Michael; Gabain Alexander v; Mattner Frank; Zauner Wolfgang
The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens.
Vaccine 2004;22(25-26):3274-84.
2002: Birnstiel Max L
The dawn of gene isolation.
Gene 2002;300(1-2):3-11.
2002: Spinelli Giovanni; Birnstiel Max L
The modulator is a constitutive enhancer of a developmentally regulated sea urchin histone H2A gene.
BioEssays : news and reviews in molecular, cellular and developmental biology 2002;24(9):850-7.
2002: Mattner Frank; Fleitmann Julia-Kristina; Lingnau Karen; Schmidt Walter; Egyed Alena; Fritz Jörg; Zauner Wolfgang; Wittmann Barbara; Gorny Irmina; Berger Manfred; Kirlappos Helen; Otava Aleksandr; Birnstiel Max L; Buschle Michael
Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens.
Cancer research 2002;62(5):1477-80.
2001: Cotten M; Baker A; Birnstiel M L; Zatloukal K; Wagner E
Preparation of adenovirus-polylysine-DNA complexes.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2001;Chapter 12():Unit 12.3.
1999: Schreiber S; Kämpgen E; Wagner E; Pirkhammer D; Trcka J; Korschan H; Lindemann A; Dorffner R; Kittler H; Kasteliz F; Küpcü Z; Sinski A; Zatloukal K; Buschle M; Schmidt W; Birnstiel M; Kempe R E; Voigt T; Weber H A; Pehamberger H; Mertelsmann R; Bröcker E B; Wolff K; Stingl G
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
Human gene therapy 1999;10(6):983-93.
1997: Schmidt W; Maass G; Buschle M; Schweighoffer T; Berger M; Herbst E; Schilcher F; Birnstiel M L
Generation of effective cancer vaccines genetically engineered to secrete cytokines using adenovirus-enhanced transferrinfection (AVET).
Gene 1997;190(1):211-6.
1997: Stingl G; Bröcker E B; Mertelsmann R; Wolff K; Schreiber S; Kämpgen E; Schneeberger A; Trcka J; Brennscheidt U; Veelken H; Birnstiel M L; Zatloukal K; Maass G; Wagner E; Buschle M; Kempe E R; Weber H A; Voigt T
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Journal of molecular medicine (Berlin, Germany) 1997;75(4):297-9.
1997: Schmidt W; Buschle M; Zauner W; Kirlappos H; Mechtler K; Trska B; Birnstiel M L
Cell-free tumor antigen peptide-based cancer vaccines.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3262-7.
1997: Buschle M; Schmidt W; Zauner W; Mechtler K; Trska B; Kirlappos H; Birnstiel M L
Transloading of tumor antigen-derived peptides into antigen-presenting cells.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3256-61.
1997: Mandl B; Brandt W F; Superti-Furga G; Graninger P G; Birnstiel M L; Busslinger M
The five cleavage-stage (CS) histones of the sea urchin are encoded by a maternally expressed family of replacement histone genes: functional equivalence of the CS H1 and frog H1M (B4) proteins.
Molecular and cellular biology 1997;17(3):1189-200.
1996: Schweighoffer T; Berger M; Buschle M; Schmidt W; Birnstiel M L
Adenovirus-enhanced receptor-mediated transferrinfection for the generation of tumor vaccines.
Cytokines and molecular therapy 1996;2(3):185-91.
1996: Schweighoffer T; Schmidt W; Buschle M; Birnstiel M L
Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccines.
Gene therapy 1996;3(9):819-24.
1996: Schmidt W; Steinlein P; Buschle M; Schweighoffer T; Herbst E; Mechtler K; Kirlappos H; Birnstiel M L
Transloading of tumor cells with foreign major histocompatibility complex class I peptide ligand: a novel general strategy for the generation of potent cancer vaccines.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(18):9759-63.
1996: Stingl G; Brocker E B; Mertelsmann R; Wolff K; Schreiber S; Kampgen E; Schneeberger A; Dummer W; Brennscheid U; Veelken H; Birnstiel M L; Zatloukal K; Schmidt W; Maass G; Wagner E; Baschle M; Giese M; Kempe E R; Weber H A; Voigt T
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Human gene therapy 1996;7(4):551-63.
1995: Maass G; Schmidt W; Berger M; Schilcher F; Koszik F; Schneeberger A; Stingl G; Birnstiel M L; Schweighoffer T
Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(12):5540-4.
1995: Buschle M; Cotten M; Kirlappos H; Mechtler K; Schaffner G; Zauner W; Birnstiel M L; Wagner E
Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex.
Human gene therapy 1995;6(6):753-61.
1995: Schmidt W; Schweighoffer T; Herbst E; Maass G; Berger M; Schilcher F; Schaffner G; Birnstiel M L
Cancer vaccines: the interleukin 2 dosage effect.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(10):4711-4.
1995: Maass G; Schweighoffer T; Berger M; Schmidt W; Herbst E; Zatloukal K; Buschle M; Birnstiel M L
Tumor vaccines: effects and fate of IL-2 transfected murine melanoma cells in vivo.
International journal of immunopharmacology 1995;17(2):65-73.
1994: Thurnher M; Wagner E; Clausen H; Mechtler K; Rusconi S; Dinter A; Birnstiel M L; Berger E G; Cotten M
Carbohydrate receptor-mediated gene transfer to human T leukaemic cells.
Glycobiology 1994;4(4):429-35.
1993: Cotten M; Wagner E; Zatloukal K; Birnstiel M L
Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants.
Journal of virology 1993;67(7):3777-85.
1993: Cotten M; Wagner E; Birnstiel M L
Receptor-mediated transport of DNA into eukaryotic cells.
Methods in enzymology 1993;217():618-44.
1992: Zatloukal K; Wagner E; Cotten M; Phillips S; Plank C; Steinlein P; Curiel D T; Birnstiel M L
Transferrinfection: a highly efficient way to express gene constructs in eukaryotic cells.
Annals of the New York Academy of Sciences 1992;660():136-53.
1992: Wagner E; Plank C; Zatloukal K; Cotten M; Birnstiel M L
Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(17):7934-8.
1992: Phillips S; Cotten M; Laengle-Rouault F; Schaffner G; Birnstiel M L
Amphibian oocytes and sphere organelles: are the U snRNA genes amplified?
Chromosoma 1992;101(9):549-56.
1992: Wagner E; Zatloukal K; Cotten M; Kirlappos H; Mechtler K; Curiel D T; Birnstiel M L
Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):6099-103.
1992: Cotten M; Wagner E; Zatloukal K; Phillips S; Curiel D T; Birnstiel M L
High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):6094-8.
1992: Phillips S C; Birnstiel M L
Analysis of a gene cluster coding for the Xenopus laevis U7 snRNA.
Biochimica et biophysica acta 1992;1131(1):95-8.
1992: Eckner R; Birnstiel M L
Evolutionary conserved multiprotein complexes interact with the 3' untranslated region of histone transcripts.
Nucleic acids research 1992;20(5):1023-30.
1991: Smith H O; Tabiti K; Schaffner G; Soldati D; Albrecht U; Birnstiel M L
Two-step affinity purification of U7 small nuclear ribonucleoprotein particles using complementary biotinylated 2'-O-methyl oligoribonucleotides.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(21):9784-8.
1991: Eckner R; Ellmeier W; Birnstiel M L
Mature mRNA 3' end formation stimulates RNA export from the nucleus.
The EMBO journal 1991;10(11):3513-22.
1991: Wagner E; Cotten M; Mechtler K; Kirlappos H; Birnstiel M L
DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety.
Bioconjugate chemistry 1991;2(4):226-31.
1991: Wagner E; Cotten M; Foisner R; Birnstiel M L
Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(10):4255-9.
1991: Cotten M; Oberhauser B; Brunar H; Holzner A; Issakides G; Noe C R; Schaffner G; Wagner E; Birnstiel M L
2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event.
Nucleic acids research 1991;19(10):2629-35.
1990: Hoffmann I; Birnstiel M L
Cell cycle-dependent regulation of histone precursor mRNA processing by modulation of U7 snRNA accessibility.
Nature 1990;346(6285):665-8.
1990: Cotten M; Längle-Rouault F; Kirlappos H; Wagner E; Mechtler K; Zenke M; Beug H; Birnstiel M L
Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4033-7.
1990: Zenke M; Steinlein P; Wagner E; Cotten M; Beug H; Birnstiel M L
Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3655-9.
1990: Wagner E; Zenke M; Cotten M; Beug H; Birnstiel M L
Transferrin-polycation conjugates as carriers for DNA uptake into cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(9):3410-4.
1990: Vasserot A P; Hoffmann I; Tabiti K; Birnstiel M L
3 processing of histone RNA precursors.
Molecular biology reports 1990;14(2-3):211-2.
1989: Cotten M; Birnstiel M L
Ribozyme mediated destruction of RNA in vivo.
The EMBO journal 1989;8(12):3861-6.
1989: Cotten M; Schaffner G; Birnstiel M L
Ribozyme, antisense RNA, and antisense DNA inhibition of U7 small nuclear ribonucleoprotein-mediated histone pre-mRNA processing in vitro.
Molecular and cellular biology 1989;9(10):4479-87.
1989: Vasserot A P; Schaufele F J; Birnstiel M L
Conserved terminal hairpin sequences of histone mRNA precursors are not involved in duplex formation with the U7 RNA but act as a target site for a distinct processing factor.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(12):4345-9.
1988: Vitelli L; Kemler I; Lauber B; Birnstiel M L; Busslinger M
Developmental regulation of micro-injected histone genes in sea urchin embryos.
Developmental biology 1988;127(1):54-63.
1988: Cotten M; Gick O; Vasserot A; Schaffner G; Birnstiel M L
Specific contacts between mammalian U7 snRNA and histone precursor RNA are indispensable for the in vitro 3' RNA processing reaction.
The EMBO journal 1988;7(3):801-8.
1988: Gilmartin G M; Schaufele F; Schaffner G; Birnstiel M L
Functional analysis of the sea urchin U7 small nuclear RNA.
Molecular and cellular biology 1988;8(3):1076-84.
1987: Gick O; Krämer A; Vasserot A; Birnstiel M L
Heat-labile regulatory factor is required for 3' processing of histone precursor mRNAs.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(24):8937-40.
1987: Schaufele F; Birnstiel M L
The inability of the Psammechinus miliaris H3 RNA to be processed in the Xenopus oocyte is associated with sequences distinct from those highly conserved amongst sea urchin histone RNAs.
Nucleic acids research 1987;15(20):8305-17.
1986: Schaufele F; Gilmartin G M; Bannwarth W; Birnstiel M L
Compensatory mutations suggest that base-pairing with a small nuclear RNA is required to form the 3' end of H3 messenger RNA.
Nature 1986;323(6091):777-81.
1986: Gick O; Krämer A; Keller W; Birnstiel M L
Generation of histone mRNA 3' ends by endonucleolytic cleavage of the pre-mRNA in a snRNP-dependent in vitro reaction.
The EMBO journal 1986;5(6):1319-26.

Sign-in to see more